Abstract:Cytochrome P450 3A4 (CYP3A4), a key enzyme, is pivotal in metabolizing approximately half of the drugs used clinically. The genetic polymorphism of the CYP3A4 gene significantly influences individual variations in drug metabolism, potentially leading to severe adverse drug reactions (ADRs). In this study, we conducted a genetic analysis on CYP3A4 gene in 1163 Chinese Han individuals to identify the genetic variations that might affect their drug metabolism capabilities. For this purpose, a multiplex polymerase chain reaction (PCR) amplicon sequencing technique was developed, enabling us to perform the genotyping of CYP3A4 gene efficiently and economically on a large scale. As a result, a total of 14 CYP3A4 allelic variants were identified, comprising six previously reported alleles and eight new nonsynonymous variants that were nominated as new allelic variants *39–*46 by the PharmVar Association. Further, functional assessments of these novel CYP3A4 variants were undertaken by coexpressing them with cytochromes P450 oxidoreductase (CYPOR) in Saccharomyces cerevisiae microsomes. Immunoblot analysis indicated that with the exception of CYP3A4.40 and CYP3A4.45, the protein expression levels of most new variants were similar to that of the wild-type CYP3A4.1 in yeast cells. To evaluate their catalytic activities, midazolam was used as a probe drug. The results showed that variant CYP3A4.45 had almost no catalytic activity, whereas the other variants exhibited significantly reduced drug metabolism abilities. This suggests that the majority of the CYP3A4 variants identified in the Chinese population possess markedly altered capacities for drug metabolism. SIGNIFICANCE STATEMENT In this study, we established a multiplex polymerase chain reaction (PCR) amplicon sequencing method and detected the maximum number of new CYP3A4 variants in a single ethnic population. Additionally, we performed the functional characterizations of these eight novel CYP3A4 allele variants in vitro. This study not only contributes to the understanding of CYP3A4 genetic polymorphism in the Chinese Han population but also holds substantial reference value for their potential clinical applications in personalized medicine.

Identification and functional analysis of fourteen NR5A1 variants in patients with the 46 XY disorders of sex development

Clinical spectrum and molecular basis in 19 Chinese patients with 46, XY disorder of sexual development caused by NR5A1 mutations

Exploring the clinical implications of novel SRD5A2 variants in 46,XY disorders of sex development

Application and insights of targeted next-generation sequencing in a large cohort of 46,XY disorders of sex development in Chinese

Next-generation Sequencing Reveals Genetic Landscape in 46, XY Disorders of Sexual Development Patients with Variable Phenotypes

[Analysis of clinical phenotype and genotype of Chinese children with disorders of sex development].

Two Novel Heterozygous Variants in RecA2 Domain of DHX37 Cause 46,XY Gonadal Dysgenesis and Testicular Regression Syndrome.

Identification of a novel homozygous NR5A1 variant in a patient with a 46,XY disorders of sex development

Targeted next-generation sequencing for the diagnosis of gene variants in patients with 46, XY disorder of sex development

NR5A1-related 46,XY partial gonadal dysgenesis: A case report and literature review

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

Characterization of 35 Novel NR5A1 /SF-1 Variants Identified in Individuals With Atypical Sexual Development: The SF1next Study

46,ΧΥ DSD in an adolescent with a novel de novo variant of the NR5A1 gene - case report and literature review

The genotype-phenotype correlation of NR5A1 variants in 46,XY individuals: A study protocol

Novel likely pathogenic variant in NR5A1 gene in a Tanzanian child with 46,XY differences of sex development, inherited from the mosaic father

Clinical and genetic characteristics of a large international cohort of individuals with rare NR5A1/SF-1 variants of sex development

A Novel SRD5A2 Mutation with Loss of Function Identified in Chinese Patients with Hypospadias.

Mutation update for the NR5A1 gene involved in DSD and infertility

NR5A1/SF-1 Collaborates with Inhibin α and the Androgen Receptor

Mutational analysis of compound heterozygous mutation p.Q6X/p.H232R in SRD5A2 causing 46,XY disorder of sex development

Phenotypic and Molecular Characteristics in Eleven Chinese Patients with 5α‐reductase Type 2 Deficiency